国产精品久久久久久永久牛牛,55国产福利在线视频,成人午夜精品视频在线观看

目錄產品 » 重組蛋白 » 生長因子 » sTRAIL R-2/TNFRSF10B, Human

sTRAIL R-2/TNFRSF10B, Human

Tumor necrosis factor-related apoptosis-inducing ligand Receptor 2 (TRAIL-R2) is a cell-surface receptor involved in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced cell-death signaling.1 The death ligand TRAIL bears high potential as a new anticancer agent, as binding to the death receptors TRAIL-R1 or TRAIL-R2 triggers apoptosis in most cancer cells.2 TRAIL-R2 has been shown to be associated with a decrease in the survival rates of breast cancer patients.
¥525
Z02934

Species Human
Protein Construction
TNFRSF10B (Glu52-Ser183)
Accession # O14763
Purity > 97% as analyzed by SDS-PAGE
> 97% as analyzed by HPLC
Endotoxin Level < 1 EU/μg of protein by LAL method
Biological Activity Fully biologically active when compared to standard. rHusTRAIL-R2 reduced the production of LPS-induced TNF by its ability to neutralize endogenous TRAIL in fresh human PBMC. In this assay, endogenous TRAIL is induced during a 24 hour exposure to LPS (10 ng/ml) but in the presence of rHusTRAIL-R2, TRAIL-induced TNF is suppressed.
Expression System E. coli
Theoretical Molecular Weight 14.8 kDa
Formulation Lyophilized from a 0.2 μm filtered solution in PBS, pH 7.4.
Reconstitution It is recommended that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute the lyophilized powder in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/ml.
Storage & Stability Upon receiving, this product remains stable for up to 6 months at -70°C or -20°C. Upon reconstitution, the product should be stable for up to 1 week at 4°C or up to 3 months at -20°C. Avoid repeated freeze-thaw cycles.
返回

STRAIL R-2/TNFRSF10B, Human

?

STRAIL R-2/TNFRSF10B, Human

?

<
>

Target Background Tumor necrosis factor-related apoptosis-inducing ligand Receptor 2 (TRAIL-R2) is a cell-surface receptor involved in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced cell-death signaling.1 The death ligand TRAIL bears high potential as a new anticancer agent, as binding to the death receptors TRAIL-R1 or TRAIL-R2 triggers apoptosis in most cancer cells.2 TRAIL-R2 has been shown to be associated with a decrease in the survival rates of breast cancer patients.
Synonyms Tumor necrosis factor receptor superfamily member 10B; Death receptor 5; TNF-related apoptosis-inducing ligand receptor 2; TRAIL receptor 2; TRAIL-R2; CD262; TNFRSF10B; DR5; KILLER; TRAILR2; TRICK2; ZTNFR9; TRICKB; TRICK2A; TRICK2B; KILLER/DR5
返回

For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.


    主站蜘蛛池模板: 大姚县| 金寨县| 浦县| 雷州市| 任丘市| 石嘴山市| 阿鲁科尔沁旗| 东源县| 富宁县| 调兵山市| 观塘区| 贞丰县| 青州市| 辽宁省| 虞城县| 民权县| 涿鹿县| 米易县| 丰城市| 永登县| 龙胜| 大埔区| 满城县| 南澳县| 石景山区| 临泉县| 赣州市| 彭泽县| 繁昌县| 松江区| 阳泉市| 澳门| 河西区| 上思县| 凤庆县| 贵州省| 凤山市| 安庆市| 辽宁省| 留坝县| 昌图县|